All articles tagged: Rheumatoid arthritis, unspecified (M06.9)

Rheumatoid arthritis (RA) patients with mono- or oligo-arthritis and high Patient Global Assessment (PGA) at diagnosis remain the most fatigued, according to a study published in the June issue of Rheumatology.Anna M.P. Boeren, from the Leiden University Medical Center in the Netherlands, and colleagues studied Disease Activity Sco

For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of major adverse cardiovascular events (MACE) and all-cause mortality, according to a research letter published online June 15 in the Journal of Rheumatology.Brittany N. Weber, M.D., Ph.D.,

The Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ) and Brief Fatigue Inventory (BFI-C) scores show consistency in assessing fatigue with rheumatoid arthritis (RA), according to a study published online June 14 in Immunity, Inflammation and Disease.Jun Zhou, from the Affiliated Suqian First People

Patients who have smoked with rheumatoid arthritis (RA) and an obstructive pattern may be a unique phenotype, according to a study published online June 17 in RMD Open.Keigo Hayashi, M.P.H., from Brigham and Women's Hospital in Boston, and colleagues compared longitudinal changes in spirometric measures over five to seven years be

The U.S. Food and Drug Administration has expanded indications for Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with polyarticular juvenile idiopathic arthritis (pJIA) and psoriatic arthritis (PsA).Rinvoq is indicated for pediatric patients with an inadequate response or intolerance to one or more tumor necros

The study reveals smoking's lasting impact on the immune system, increasing vulnerability to diseases even after quitting. Despite declining rates, smoking remains the leading cause of preventable deaths in the US. Quitting improves immunity but doesn't fully recover it, emphasizing the importance of cessation.

Gastroesophageal reflux disease (GERD) causally and positively influences rheumatoid arthritis (RA), but RA has no significant influence on GERD, according to a study published online Dec. 13 in Frontiers in Genetics.Haifan Wang, from The Second Affiliated Hospital of Xi'an Jiaotong University in China, and colleagues examined the bi

Certain hormonal and reproductive factors are associated with an increased risk for rheumatoid arthritis (RA) among women, according to a study published online Jan. 9 in RMD Open.Ling-Qiong Jiang, from the Anhui Medical University School of Public Health in Hefei, China, and colleagues collected data on hormonal and reproductive fac

Disease-modifying antirheumatic drugs (DMARDs) might prevent incidence of autoimmune thyroid disease (AITD) in patients with rheumatoid arthritis (RA), according to a study recently published in the Journal of Internal Medicine.Kristin Waldenlind, M.D., Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined

Globally, 494 million people had other musculoskeletal disorders in 2020, with a 115 percent increase projected to 2050, according to a study published online in the November issue of The Lancet Rheumatology.Tiffany K. Gill, Ph.D., from the University of Adelaide in Australia, and colleagues estimated the prevalence of other musculoskel

For patients with rheumatoid arthritis, the efficacy and safety of four Janus kinase (JAK) inhibitors is comparable, according to a study published online Nov. 1 in Rheumatology.Shinya Hayashi, M.D., from the Kobe University Graduate School of Medicine in Japan, and colleagues conducted a multicenter, retrospective study comparing the ef

For patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs (DMARDs), receiving a fourth COVID-19 mRNA vaccine reduces the risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published online Nov. 15 in The Lancet Rheumatology.Jennifer S. Hanberg

Oral contraceptive use appears to protect against rheumatoid arthritis (RA), while menopausal hormone therapy (MHT) use may increase the risk for late-onset RA, according to a study published online Sept. 29 in Rheumatology. Fatemeh Hadizadeh, M.D., Ph.D., from Uppsala University in Sweden, and colleagues estimated the effec